Pfizer Inc (PFE) 29.28 $PFE
How the Dow Jones industrial average fared Monday
By The Associated Press - AP - 21 mins ago
The stock market drifted to a higher finish on Monday. With no major new economic data to chew on, investors focused on a batch of news on corporate deals, including AT&T's proposed takeover of satellite TV provider DirecTV; the latest development in Pfizer's bid to acquire rival drugmaker AstraZeneca and Abbott Laboratories' proposed acquisition of CFR Pharmaceuticals.
Stocks Close Higher as Small-Caps, Techs Gain
at The Street - 22 mins ago
U.S. stocks move higher Monday as small-cap and tech stocks gain against a backdrop of mixed M&A success. Talks between AstraZeneca and Pfizer appear to have broken down while sentiment is cool over an AT&T and DirecTV deal.
Stocks edge higher after drifting in early trade
By ALEX VEIGA - AP - 26 mins ago
Stocks finished slightly higher on Monday, adding to the small gains the market carved out at the end of last week.
Why Pfizer (PFE) Stock is Up Today (Update)
at The Street - 53 mins ago
Pfizer (PFE) rose Monday after AstraZeneca (AZN) rejected what the U.S. pharmaceutical company said was its final increased offer to purchase the British company.
AstraZeneca and AT&T are big market movers
AP - 54 mins ago
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
Why AstraZeneca (AZN) Stock Continues to Decline
at The Street - 1 hr 41 mins ago
Now that the AstraZeneca has named its price--$125 billion-- will anyone else step up?
Final Hour: Techs, Treasuries, Small Caps Boost Otherwise Sideways Shuffle
at The Street - 2 hrs 8 mins ago
As indices fluctuated in a directionless day of trade, investors could be fooled for thinking there's little more than a sideways shuffle happening in markets. But key drivers are machinating beneath the surface: a rolling correction in tech stocks,...
Obama touts business influx; some firms exit, too
By JIM KUHNHENN - AP - 2 hrs 42 mins ago
WASHINGTON (AP) — While in Brussels for talks with European leaders in March, President Barack Obama held a little-noticed meeting with executives of a Belgian aerospace company. It was barely a footnote in a trip dominated by tensions with Russia over Ukraine.
Why AstraZeneca PLC Shares Tumbled
Sean Williams, The Motley Fool - Motley Fool - Mon May 19, 1:21PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of AstraZeneca , a global branded...
Most active New York Stock Exchange-traded stocks
AP - Mon May 19, 12:22PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:
Midday Glance: Pharmaceuticals companies
AP - Mon May 19, 12:21PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Pfizer's Other Big News
Todd Campbell, The Motley Fool - Motley Fool - Mon May 19, 12:05PM CDT
Pfizer has confirmed plans to file its promising breast cancer drug palbociclib for FDA approval in the third quarter. If approved, Pfizer could enjoy significant revenue, given it will be dosed alongside Novartis ' Femara, a breast cancer...
These 2 Megamergers are Moving the Dow Today
Jay Jenkins, The Motley Fool - Motley Fool - Mon May 19, 12:02PM CDT
The Dow Jones Industrial Average dropped back into the red in early afternoon trading Monday, down five points as of 1 p.m. EDT. Dominating the headlines Monday morning was news of two megadeals, one on the ropes and one just getting started. ...
One Put, One Call Option To Know About For Pfizer
at The Street - Mon May 19, 11:25AM CDT
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc . So this week we highlight one interesting put contract, and one interesting call contract, from the March 2015...
AstraZeneca rejects $119 billion offer from Pfizer
By GREGORY KATZ and LINDA A. JOHNSON - AP - Mon May 19, 11:15AM CDT
LONDON (AP) — The board of AstraZeneca on Monday rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, a decision that caused a sharp slide in the U.K. company's share price as many investors think it effectively brings an end to the protracted and increasingly bitter takeover saga.
Markets subdued despite AT&T bid for DirecTV
By PAN PYLAS - AP - Mon May 19, 11:04AM CDT
LONDON (AP) — Markets were subdued Monday as investors assessed the latest corporate news, including a possible merger between AT&T and DirecTV.
4th Time Not (Yet) the Charm for Pfizer
Stephen D., Simpson,, The Motley Fool - Motley Fool - Mon May 19, 11:01AM CDT
Pfizer is certainly not letting AstraZeneca slip away without a good fight. While Pfizer has been on a charm offense on both sides of the ocean trying to convince politicians that the deal is a legitimate business combination...
Stocks edge higher as investors asses deal news
AP - Mon May 19, 10:59AM CDT
NEW YORK (AP) — Stocks are edging higher in midday trading as investors consider the latest news on corporate mergers.
AstraZeneca Rejects Raised Pfizer Bid; Stock Falls
at Investor's Business Daily - Mon May 19, 10:07AM CDT
AstraZeneca (AZN) early Monday rejected a raised takeover bid from Pfizer (PFE), which Pfizer called its "final proposal" to the British drug giant. AstraZeneca stock tumbled 10% in morning trading on the stock market today, while Pfizer stock was up...
AstraZeneca Rejects Pfizer's Final Offer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 19, 10:07AM CDT
AstraZeneca (AZN) announced that it has rejected Pfizer's (PFE) latest takeover proposal.
How the Dow Jones industrial average fared Monday
By The Associated Press - AP - 21 mins ago
The stock market drifted to a higher finish on Monday. With no major new economic data to chew on, investors focused on a batch of news on corporate deals, including AT&T's proposed takeover of satellite TV provider DirecTV; the latest development in Pfizer's bid to acquire rival drugmaker AstraZeneca and Abbott Laboratories' proposed acquisition of CFR Pharmaceuticals.
Stocks Close Higher as Small-Caps, Techs Gain
at The Street - 22 mins ago
U.S. stocks move higher Monday as small-cap and tech stocks gain against a backdrop of mixed M&A success. Talks between AstraZeneca and Pfizer appear to have broken down while sentiment is cool over an AT&T and DirecTV deal.
Stocks edge higher after drifting in early trade
By ALEX VEIGA - AP - 26 mins ago
Stocks finished slightly higher on Monday, adding to the small gains the market carved out at the end of last week.
Why Pfizer (PFE) Stock is Up Today (Update)
at The Street - 53 mins ago
Pfizer (PFE) rose Monday after AstraZeneca (AZN) rejected what the U.S. pharmaceutical company said was its final increased offer to purchase the British company.
AstraZeneca and AT&T are big market movers
AP - 54 mins ago
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
Why AstraZeneca (AZN) Stock Continues to Decline
at The Street - 1 hr 41 mins ago
Now that the AstraZeneca has named its price--$125 billion-- will anyone else step up?
Final Hour: Techs, Treasuries, Small Caps Boost Otherwise Sideways Shuffle
at The Street - 2 hrs 8 mins ago
As indices fluctuated in a directionless day of trade, investors could be fooled for thinking there's little more than a sideways shuffle happening in markets. But key drivers are machinating beneath the surface: a rolling correction in tech stocks,...
Obama touts business influx; some firms exit, too
By JIM KUHNHENN - AP - 2 hrs 42 mins ago
WASHINGTON (AP) — While in Brussels for talks with European leaders in March, President Barack Obama held a little-noticed meeting with executives of a Belgian aerospace company. It was barely a footnote in a trip dominated by tensions with Russia over Ukraine.
Why AstraZeneca PLC Shares Tumbled
Sean Williams, The Motley Fool - Motley Fool - Mon May 19, 1:21PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of AstraZeneca , a global branded...
Most active New York Stock Exchange-traded stocks
AP - Mon May 19, 12:22PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:
Midday Glance: Pharmaceuticals companies
AP - Mon May 19, 12:21PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Pfizer's Other Big News
Todd Campbell, The Motley Fool - Motley Fool - Mon May 19, 12:05PM CDT
Pfizer has confirmed plans to file its promising breast cancer drug palbociclib for FDA approval in the third quarter. If approved, Pfizer could enjoy significant revenue, given it will be dosed alongside Novartis ' Femara, a breast cancer...
These 2 Megamergers are Moving the Dow Today
Jay Jenkins, The Motley Fool - Motley Fool - Mon May 19, 12:02PM CDT
The Dow Jones Industrial Average dropped back into the red in early afternoon trading Monday, down five points as of 1 p.m. EDT. Dominating the headlines Monday morning was news of two megadeals, one on the ropes and one just getting started. ...
One Put, One Call Option To Know About For Pfizer
at The Street - Mon May 19, 11:25AM CDT
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc . So this week we highlight one interesting put contract, and one interesting call contract, from the March 2015...
AstraZeneca rejects $119 billion offer from Pfizer
By GREGORY KATZ and LINDA A. JOHNSON - AP - Mon May 19, 11:15AM CDT
LONDON (AP) — The board of AstraZeneca on Monday rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, a decision that caused a sharp slide in the U.K. company's share price as many investors think it effectively brings an end to the protracted and increasingly bitter takeover saga.
Markets subdued despite AT&T bid for DirecTV
By PAN PYLAS - AP - Mon May 19, 11:04AM CDT
LONDON (AP) — Markets were subdued Monday as investors assessed the latest corporate news, including a possible merger between AT&T and DirecTV.
4th Time Not (Yet) the Charm for Pfizer
Stephen D., Simpson,, The Motley Fool - Motley Fool - Mon May 19, 11:01AM CDT
Pfizer is certainly not letting AstraZeneca slip away without a good fight. While Pfizer has been on a charm offense on both sides of the ocean trying to convince politicians that the deal is a legitimate business combination...
Stocks edge higher as investors asses deal news
AP - Mon May 19, 10:59AM CDT
NEW YORK (AP) — Stocks are edging higher in midday trading as investors consider the latest news on corporate mergers.
AstraZeneca Rejects Raised Pfizer Bid; Stock Falls
at Investor's Business Daily - Mon May 19, 10:07AM CDT
AstraZeneca (AZN) early Monday rejected a raised takeover bid from Pfizer (PFE), which Pfizer called its "final proposal" to the British drug giant. AstraZeneca stock tumbled 10% in morning trading on the stock market today, while Pfizer stock was up...
AstraZeneca Rejects Pfizer's Final Offer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 19, 10:07AM CDT
AstraZeneca (AZN) announced that it has rejected Pfizer's (PFE) latest takeover proposal.
